Literature DB >> 2871065

Alpha-1 adrenergic blockade: a possible mechanism of action of dopaminergic drugs on ACTH secretion.

M Boscaro, A M Menegus, F Mantero.   

Abstract

In some cases of Cushing's syndrome both bromocriptine and lisuride inhibit the secretion of ACTH but it is still unknown if they act at pituitary or at higher levels. In order to evaluate this aspect, we set up an in vitro perfusion system with anterior pituitary cells from rats and from human ACTH-secreting tumors. In both preparations lysine-vasopressin (LVP) and epinephrine (EPI) stimulated ACTH secretion; prazosin (alpha-1 blocker) inhibited the EPI but not the LVP-mediated stimulation. Similarly, the infusion of lisuride blocked ACTH response to EPI but not to LVP. These data may suggest that "dopaminergic" drugs could act by an adrenergic blockade and not necessarily by a dopaminergic inhibition.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2871065     DOI: 10.1007/BF03348553

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  19 in total

1.  Neurotransmitters involved in ACTH secretion: catecholamines.

Authors:  W F Ganong
Journal:  Ann N Y Acad Sci       Date:  1977-10-28       Impact factor: 5.691

2.  Effect of dopamine on the biological activity and in vitro release of ACTH and FSH.

Authors:  G R Van Loon; C L Kragt
Journal:  Proc Soc Exp Biol Med       Date:  1970-04

3.  Adrenergic blockade and the corticosteroid and growth hormone responses to methylamphetamine.

Authors:  L Rees; P W Butler; C Gosling; G M Besser
Journal:  Nature       Date:  1970-11-07       Impact factor: 49.962

4.  Characteristics of the alpha-adrenergic stimulation of adrenocorticotropin secretion in rat anterior pituitary cells.

Authors:  V Giguere; J Cote; F Labrie
Journal:  Endocrinology       Date:  1981-09       Impact factor: 4.736

5.  Adrenocorticotropin-secreting pituitary adenomas originate from the anterior or the intermediate lobe in Cushing's disease: differences in the regulation of hormone secretion.

Authors:  S W Lamberts; S A de Lange; S Z Stefanko
Journal:  J Clin Endocrinol Metab       Date:  1982-02       Impact factor: 5.958

6.  Tyrosine hydroxylase and dopamine-beta-hydroxylase: distribution in the individual rat hypothalamic nuclei.

Authors:  J M Saavedra; M Brownstein; M Palkovits; S Kizer; J Axelrod
Journal:  J Neurochem       Date:  1974-10       Impact factor: 5.372

7.  The effects of dopamine, bromocriptine, lergotrile and metoclopramide on prolactin release from continuously perfused columns of isolated rat pituitary cells.

Authors:  T Yeo; M O Thorner; A Jones; P J Lowry; G M Besser
Journal:  Clin Endocrinol (Oxf)       Date:  1979-02       Impact factor: 3.478

8.  Effect of short and long-term administration of lisuride in Cushing's disease.

Authors:  M Boscaro; G Merola; E Serafini; F Mantero
Journal:  J Endocrinol Invest       Date:  1985-02       Impact factor: 4.256

9.  Parallel stimulation of ACTH, beta-LPH + beta-endorphin and alpha-MSH release by alpha-adrenergic agents in rat anterior pituitary cells in culture.

Authors:  V Raymond; J Lépine; V Giguère; J C Lissitzky; J Côté; F Labrie
Journal:  Mol Cell Endocrinol       Date:  1981-06       Impact factor: 4.102

10.  Bromocriptine suppresses ACTH secretion from human pituitary tumour cells in culture by a dopaminergic mechanism.

Authors:  E F Adams; M J Ashby; S M Brown; M C White; K Mashiter
Journal:  Clin Endocrinol (Oxf)       Date:  1981-11       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.